These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 34035524)

  • 1. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection.
    Montefusco L; Ben Nasr M; D'Addio F; Loretelli C; Rossi A; Pastore I; Daniele G; Abdelsalam A; Maestroni A; Dell'Acqua M; Ippolito E; Assi E; Usuelli V; Seelam AJ; Fiorina RM; Chebat E; Morpurgo P; Lunati ME; Bolla AM; Finzi G; Abdi R; Bonventre JV; Rusconi S; Riva A; Corradi D; Santus P; Nebuloni M; Folli F; Zuccotti GV; Galli M; Fiorina P
    Nat Metab; 2021 Jun; 3(6):774-785. PubMed ID: 34035524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection.
    Laurenzi A; Caretto A; Molinari C; Mercalli A; Melzi R; Nano R; Tresoldi C; Rovere Querini P; Ciceri F; Lampasona V; Bosi E; Scavini M; Piemonti L
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1009-e1019. PubMed ID: 34718627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection.
    Guardado-Mendoza R; Garcia-Magaña MA; Martínez-Navarro LJ; Macías-Cervantes HE; Aguilar-Guerrero R; Suárez-Pérez EL; Aguilar-García A
    Sci Rep; 2022 Jan; 12(1):536. PubMed ID: 35017617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia.
    Wan L; Gao Q; Deng Y; Ke Y; Ma E; Yang H; Lin H; Li H; Yang Y; Gong J; Li J; Xu Y; Liu J; Li J; Liu J; Zhang X; Huang L; Feng J; Zhang Y; Huang H; Wang H; Wang C; Chen Q; Huang X; Ye Q; Li D; Yan Q; Liu M; Wei M; Mo Y; Li D; Tang K; Lin C; Zheng F; Xu L; Cheng G; Wang P; Yang X; Wu F; Sun Z; Qin C; Wei C; Zhong H
    Nat Metab; 2022 Jan; 4(1):29-43. PubMed ID: 34992299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients.
    Marfella R; Paolisso P; Sardu C; Bergamaschi L; D'Angelo EC; Barbieri M; Rizzo MR; Messina V; Maggi P; Coppola N; Pizzi C; Biffi M; Viale P; Galié N; Paolisso G
    Diabetes Metab; 2020 Oct; 46(5):403-405. PubMed ID: 32447102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and diabetes: A bidirectional relationship.
    Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
    Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe COVID-19 associated hyperglycemia is caused by beta cell dysfunction: a prospective cohort study.
    Gojda J; Koudelková K; Ouřadová A; Lang A; Krbcová M; Gvozdeva A; Šebo V; Slagmolen L; Potočková J; Tůma P; Rossmeislová L; Anděl M; Karpe F; Schlesinger S
    Nutr Diabetes; 2023 Jul; 13(1):11. PubMed ID: 37460458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
    Zhang W; Li C; Xu Y; He B; Hu M; Cao G; Li L; Wu S; Wang X; Zhang C; Zhao J; Xie J; Xu Z; Li Q; Wang G
    Mediators Inflamm; 2021; 2021():8812304. PubMed ID: 33814982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.
    Zhu B; Wei X; Narasimhan H; Qian W; Zhang R; Cheon IS; Wu Y; Li C; Jones RG; Kaplan MH; Vassallo RA; Braciale TJ; Somerville L; Colca JR; Pandey A; Jackson PEH; Mann BJ; Krawczyk CM; Sturek JM; Sun J
    Sci Immunol; 2023 Apr; 8(82):eadf0348. PubMed ID: 36821695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients.
    Ilias I; Diamantopoulos A; Pratikaki M; Botoula E; Jahaj E; Athanasiou N; Tsipilis S; Zacharis A; Vassiliou AG; Vassiliadi DA; Kotanidou A; Tsagarakis S; Dimopoulou I
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33466617
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients.
    Soto ME; Guarner-Lans V; Díaz-Díaz E; Manzano-Pech L; Palacios-Chavarría A; Valdez-Vázquez RR; Aisa-Álvarez A; Saucedo-Orozco H; Pérez-Torres I
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of hyperglycemia and glucose variability in covid-related acute respiratory distress Syndrome.
    Lazzeri C; Bonizzoli M; Batacchi S; Di Valvasone S; Chiostri M; Peris A
    Diabetes Res Clin Pract; 2021 May; 175():108789. PubMed ID: 33812902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors.
    He X; Liu C; Peng J; Li Z; Li F; Wang J; Hu A; Peng M; Huang K; Fan D; Li N; Zhang F; Cai W; Tan X; Hu Z; Deng X; Li Y; Mo X; Li L; Shi Y; Yang L; Zhu Y; Wu Y; Liang H; Liao B; Hong W; He R; Li J; Guo P; Zhuo Y; Zhao L; Hu F; Li W; Zhu W; Zhang Z; Guo Z; Zhang W; Hong X; Cai W; Gu L; Du Z; Zhang Y; Xu J; Zuo T; Deng K; Yan L; Chen X; Chen S; Lei C
    Signal Transduct Target Ther; 2021 Dec; 6(1):427. PubMed ID: 34916489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients.
    Ilias I; Jahaj E; Kokkoris S; Zervakis D; Temperikidis P; Magira E; Pratikaki M; Vassiliou AG; Routsi C; Kotanidou A; Dimopoulou I
    In Vivo; 2020; 34(5):3029-3032. PubMed ID: 32871848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
    Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
    Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.
    Samuel SM; Varghese E; Büsselberg D
    Trends Microbiol; 2021 Oct; 29(10):894-907. PubMed ID: 33785249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.